Editorial - Pathologic T2 Stage Subgroups and Recurrence-Free Survival After Radical Prostatectomy
BERKELEY, CA (UroToday.com) - In the online version of Urology, Dr. James McKiernan and a group of investigators at Columbia University reported that while clinical subgroups of stage cT2 prostate cancer (CaP) have prognostic significance, pathologic subgroups of stage pT2 do not.
 | Written by Christopher P. Evans, MD, a Contributing Editor with UroToday. |
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 UroToday International Journal Correspondence
Privacy Policy | © 2010 UroToday ® All Rights Reserved |
